Related Experiment Video
Updated: Oct 9, 2025
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
Published on: February 28, 2015
A quantitative view of strategies to engineer cell-selective ligand binding
Zhixin Cyrillus Tan1, Brian T Orcutt-Jahns2, Aaron S Meyer1,2,3,4
1Bioinformatics Interdepartmental Program, University of California, Los Angeles, CA 90024, USA.
Abstract:
A critical property of many therapies is their selective binding to target populations. Exceptional specificity can arise from high-affinity binding to surface targets expressed exclusively on target cell types. In many cases, however, therapeutic targets are only expressed at subtly different levels relative to off-target cells. More complex binding strategies have been developed to overcome this limitation, including multi-specific and multivalent molecules, creating a combinatorial explosion of design possibilities. Guiding strategies for developing cell-specific binding are critical to employ these tools. Here, we employ a uniquely general multivalent binding model to dissect multi-ligand and multi-receptor interactions. This model allows us to analyze and explore a series of mechanisms to engineer cell selectivity, including mixtures of molecules, affinity adjustments, valency changes, multi-specific molecules and ligand competition. Each of these strategies can optimize selectivity in distinct cases, leading to enhanced selectivity when employed together. The proposed model, therefore, provides a comprehensive toolkit for the model-driven design of selectively binding therapies.
Insights
Designing targeted therapies requires precise cell binding. This study introduces a general multivalent binding model to engineer cell selectivity by analyzing various molecular interactions for enhanced therapeutic design.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Therapeutic efficacy relies on selective binding to target cells.
- Subtle differences in target expression levels pose challenges for specificity.
- Advanced strategies like multi-specific and multivalent molecules offer solutions but increase design complexity.
Purpose of the Study:
- To develop a general multivalent binding model for dissecting multi-ligand and multi-receptor interactions.
- To explore and analyze mechanisms for engineering cell-specific binding.
- To provide a framework for model-driven design of selectively binding therapies.
Main Methods:
- Employed a general multivalent binding model.
- Analyzed interactions involving mixtures of molecules, affinity adjustments, valency changes, multi-specific molecules, and ligand competition.
- Investigated strategies to engineer cell selectivity.
Main Results:
- Demonstrated that various strategies (affinity, valency, multi-specificity, competition) can optimize selectivity.
- Showed that combining these strategies can lead to further enhanced selectivity.
- Validated the model's utility in exploring design possibilities for cell-specific binding.
Conclusions:
- The proposed multivalent binding model offers a comprehensive toolkit for designing therapies with improved cell selectivity.
- Model-driven approaches are crucial for navigating the combinatorial complexity of advanced binding strategies.
- This work facilitates the development of more effective and safer targeted therapies.
Related Concept Videos
02:40Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:18The Equilibrium Binding Constant and Binding Strength